Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP919032.RA4BVm9sRRqF0JC8WnUt9h_3babigNqXssqeIS5-hqKBU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP919032.RA4BVm9sRRqF0JC8WnUt9h_3babigNqXssqeIS5-hqKBU130_assertion type Assertion NP919032.RA4BVm9sRRqF0JC8WnUt9h_3babigNqXssqeIS5-hqKBU130_head.
- NP919032.RA4BVm9sRRqF0JC8WnUt9h_3babigNqXssqeIS5-hqKBU130_assertion wasGeneratedBy ECO_0000203 NP919032.RA4BVm9sRRqF0JC8WnUt9h_3babigNqXssqeIS5-hqKBU130_provenance.
- NP919032.RA4BVm9sRRqF0JC8WnUt9h_3babigNqXssqeIS5-hqKBU130_assertion wasDerivedFrom befree-20150227 NP919032.RA4BVm9sRRqF0JC8WnUt9h_3babigNqXssqeIS5-hqKBU130_provenance.
- NP919032.RA4BVm9sRRqF0JC8WnUt9h_3babigNqXssqeIS5-hqKBU130_assertion SIO_000772 16609019 NP919032.RA4BVm9sRRqF0JC8WnUt9h_3babigNqXssqeIS5-hqKBU130_provenance.
- NP919032.RA4BVm9sRRqF0JC8WnUt9h_3babigNqXssqeIS5-hqKBU130_assertion evidence source_evidence_literature NP919032.RA4BVm9sRRqF0JC8WnUt9h_3babigNqXssqeIS5-hqKBU130_provenance.
- NP919032.RA4BVm9sRRqF0JC8WnUt9h_3babigNqXssqeIS5-hqKBU130_assertion description "[A high HOXB13/IL-17BR expression ratio is associated with increased relapse and death in patients with resected node-negative, ER-positive breast cancer treated with tamoxifen and may identify patients in whom alternative therapies should be studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919032.RA4BVm9sRRqF0JC8WnUt9h_3babigNqXssqeIS5-hqKBU130_provenance.